Levocetirizina Sandoz

Levocetirizine, the active ingredient in Levocetirizina Sandoz, is an antihistamine presented as an oral tablet for oral use. It reduces symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children when prescribed by a healthcare professional.

GNH USA supplies Levocetirizina Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine is an H1‑antihistamine used to manage allergic conditions by blocking peripheral histamine receptors.

Allergic rhinitis: relief of sneezing, itching, watery eyes and nasal congestion. Seasonal allergic rhinitis: reduction of seasonal nasal and ocular symptoms. Chronic idiopathic urticaria: decrease in hives and associated itching.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or fatigue - Dry mouth - Headache - Nausea - Altered taste perception - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Angioedema or severe swelling - Anaphylactic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Significant tachycardia - Hepatic injury - Hematologic abnormalities such as agranulocytosis

When prescribing Levocetirizina Sandoz, clinicians should consider several safety aspects. - Renal function assessment: dose adjustment may be needed in severe impairment. - Elderly patients: monitor for increased sedation. - Driving or operating machinery: advise caution if drowsiness occurs. - Concomitant CNS depressants: evaluate additive sedative effects. - History of hypersensitivity: avoid if prior allergic reaction to levocetirizine. - Store at below 25°C: keep in the original pack, protect from moisture.

Levocetirizine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other H1‑antihistamines: increased risk of excessive sedation. - Central nervous system depressants (e.g., benzodiazepines): additive drowsiness. - Monoamine oxidase inhibitors: potential for heightened antihistaminic effects.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance sedation and impair coordination. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): possible increase in plasma levocetirizine levels. - Ritonavir: may raise exposure and require clinical observation.